- ►diabetesjournals.org L Tedesco, A Valerio, C Cervino, A Cardile, C Pagano, … - Diabetes, 2008 - Am Diabetes Assoc RESULTS—SR141716 treatment increased eNOS expression in cultured white adipocytes.
Moreover, SR141716 increased mitochondrial DNA amount, mRNA levels of genes involved
in mitochondrial biogenesis, and mitochondrial mass and function through eNOS ... Cited by 12 - Related articles - All 4 versions
- ►diabetesjournals.org [PDF] L Tedesco, A Valerio, C Cervino, A Cardile, C Pagano, … - Diabetes, 2008 - Am Diabetes Assoc Page 1. CB1 receptors and mitochondrial biogenesis Cannabinoid type 1 receptor blockade
promotes mitochondrial biogenesis through eNOS expression in white adipocytes Laura Tedesco,
1,2 Alessandra Valerio, 1,3 Cristina Cervino, 4 Annalisa Cardile, 1 Claudio ... Cited by 3 - Related articles - All 2 versions
T Watanabe, N Kubota, M Ohsugi, T Kubota, I … - Journal of Biological …, 2009 - ASBMB Rimonabant has been shown to not only decrease the food intake and body weight but also
to increase serum adiponectin levels. This increase of the serum adiponectin levels has been
hypothesized to be related to the rimonabant-induced amelioration of insulin resistance ... Cited by 7 - Related articles - All 3 versions
R Nogueiras, C Veyrat-Durebex, PM Suchanek, M … - Diabetes, 2008 - Am Diabetes Assoc OBJECTIVE—Blockade of the CB1 receptor is one of the promising strategies for the treatment
of obesity. Although antagonists suppress food intake and reduce body weight, the role of central
versus peripheral CB1 activation on weight loss and related metabolic parameters ... Cited by 11 - Related articles - All 5 versions
[CITATION] Effects of the CB1 antagonist SR141716A (Rimonabant) on energy expenditure …
H Dernbach, J Haller, T Kaulisch, T Lehmann-Lintz, M … - Obesity Rev, 2005 Cited by 4 - Related articles
[CITATION] Integration of leptin signalling in an appetite-related neural circuit
S Migrenne, A Lacombe, AL Lefevre, MP … - American Journal of …, 2009 - Am Physiological Soc The increase in adiponectin levels in obese patients with untreated dyslipidemia and its mRNA
expression in adipose tissue of obese animals are one of the most interesting consequences
of rimonabant treatment. Thus, part of rimonabant's metabolic effects could be related to ... Cited by 5 - Related articles - All 3 versions
R Motaghedi, TE McGraw - 2008 - nature.com Mounting evidence suggests that the endocannabinoid system regulates energy metabolism
through direct effects on peripheral tissues as well as central effects that regulate appetite. Here
we examined the effect of cannabinoid receptor 1 (CB1) signaling on insulin action in fat ... Cited by 5 - Related articles - All 3 versions
G Voros, JD Sandy, D Collen, HR Lijnen - BBA-General Subjects, 2006 - Elsevier The expression and potential functional role of aggrecan in adipogenesis and adipose tissue
development was investigated in murine models of obesity. Aggrecan, as well as the two aggrecanases
ADAMTS-4 and ADAMTS-5 (A Disintegrin And Metalloproteinase with Thrombospondin ... Cited by 6 - Related articles - All 5 versions
- ►endojournals.org AW Herling, S Kilp, R Elvert, G Haschke, W Kramer - Endocrinology, 2008 - Endocrine Soc The CB1 receptor antagonist, rimonabant, affects the endocannabinoid system and causes a
sustained reduction in body weight (BW) despite the transient nature of the reduction in food
intake. Therefore, in a multiple-dose study, female candy-fed Wistar rats were treated with ... Cited by 15 - Related articles - BL Direct - All 4 versions
